SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘10-Q’ for 6/30/15 – ‘EX-101.SCH’

On:  Monday, 8/10/15, at 4:05pm ET   ·   For:  6/30/15   ·   Accession #:  1564590-15-6825   ·   File #:  1-35996

Previous ‘10-Q’:  ‘10-Q’ on 2/6/15 for 12/31/14   ·   Next:  ‘10-Q’ on 11/9/15 for 9/30/15   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/10/15  Organovo Holdings, Inc.           10-Q        6/30/15   46:3.9M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    299K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
29: R1          Document and Entity Information                     HTML     38K 
22: R2          Condensed Consolidated Balance Sheets               HTML     94K 
27: R3          Condensed Consolidated Balance Sheets               HTML     28K 
                (Parenthetical)                                                  
31: R4          Unaudited Condensed Consolidated Statements of      HTML     55K 
                Operations                                                       
42: R5          Unaudited Condensed Consolidated Statements of      HTML     89K 
                Cash Flows                                                       
23: R6          Unaudited Condensed Consolidated Statements of      HTML     21K 
                Cash Flows (Parenthetical)                                       
26: R7          Description of Business and Summary of Significant  HTML    114K 
                Accounting Policies                                              
20: R8          Derivative Liability                                HTML     66K 
15: R9          Stockholders' Equity                                HTML    152K 
43: R10         Commitments and Contingencies                       HTML     52K 
33: R11         Concentrations                                      HTML     23K 
32: R12         Recent Accounting Pronouncements                    HTML     26K 
37: R13         Subsequent Events                                   HTML     19K 
38: R14         Description of Business and Summary of Significant  HTML    184K 
                Accounting Policies (Policies)                                   
36: R15         Description of Business and Summary of Significant  HTML     76K 
                Accounting Policies (Tables)                                     
39: R16         Derivative Liability (Tables)                       HTML     60K 
28: R17         Stockholders' Equity (Tables)                       HTML    136K 
30: R18         Commitments and Contingencies (Tables)              HTML     34K 
35: R19         Description of Business and Summary of Significant  HTML     82K 
                Accounting Policies - Additional Information                     
                (Detail)                                                         
46: R20         Description of Business and Summary of Significant  HTML     31K 
                Accounting Policies - Estimated Fair Values of                   
                Liabilities Measured on Recurring Basis (Detail)                 
40: R21         Description of Business and Summary of Significant  HTML     32K 
                Accounting Policies - Activity for Liabilities                   
                Measured at Estimated Fair Value Using                           
                Unobservable Inputs (Detail)                                     
24: R22         Derivative Liability - Additional Information       HTML     36K 
                (Detail)                                                         
34: R23         Derivative Liability - Assumptions Used to Value    HTML     33K 
                Derivative Liabilities at Closing Dates of Private               
                Placements (Detail)                                              
25: R24         Stockholders' Equity - Additional Information       HTML    145K 
                (Detail)                                                         
13: R25         Stockholders' Equity - Summary of Company's         HTML     29K 
                Restricted Stock Award Activity (Detail)                         
41: R26         Stockholders' Equity - Additional Information 1     HTML     54K 
                (Detail)                                                         
44: R27         Stockholders' Equity - Summary of Stock Option      HTML     52K 
                Activity (Detail)                                                
17: R28         Stockholders' Equity - Fair Value of Employee       HTML     32K 
                Stock Options (Detail)                                           
16: R29         Stockholders' Equity - Additional Information 2     HTML     78K 
                (Detail)                                                         
18: R30         Stockholders' Equity - Summary of Warrant Activity  HTML     44K 
                (Detail)                                                         
19: R31         Stockholders' Equity - Common Stock Reserved for    HTML     27K 
                Future Issuance (Detail)                                         
21: R32         Commitments and Contingencies - Additional          HTML     49K 
                Information (Detail)                                             
12: R33         Commitments and Contingencies - Future Minimum      HTML     38K 
                Rental Payments Required under Operating Leases                  
                that have Initial or Remaining Non-Cancelable                    
                Lease Terms in Excess of One Year (Detail)                       
45: XML         IDEA XML File -- Filing Summary                      XML     78K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX     56K 
 5: EX-101.INS  XBRL Instance -- onvo-20150630                       XML   1.01M 
 7: EX-101.CAL  XBRL Calculations -- onvo-20150630_cal               XML     90K 
 8: EX-101.DEF  XBRL Definitions -- onvo-20150630_def                XML    303K 
 9: EX-101.LAB  XBRL Labels -- onvo-20150630_lab                     XML    742K 
10: EX-101.PRE  XBRL Presentations -- onvo-20150630_pre              XML    570K 
 6: EX-101.SCH  XBRL Schema -- onvo-20150630                         XSD    102K 
14: ZIP         XBRL Zipped Folder -- 0001564590-15-006825-xbrl      Zip     99K 


‘EX-101.SCH’   —   XBRL Schema — onvo-20150630


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- RRD ActiveDisclosure(SM) XBRL Schema Document - http://www.financial.rrd.com/ -->
<!-- Creation Date : 2015-08-07T15:40:57.9322706+00:00 -->
<!-- Version : 2.0.9.1 -->
<!-- Package ID : ABD5B3EBBD90C95D962954E902EFD42B-0001497253-001506 -->
<!-- Copyright (c) 2015 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:onvo="http://www.organovo.com/20150630" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.organovo.com/20150630" xmlns="http://www.w3.org/2001/XMLSchema">
<import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
<import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
<import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
<import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric"/>
<import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric"/>
<import schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd" namespace="http://fasb.org/us-types/2015-01-31"/>
<import schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd" namespace="http://fasb.org/us-gaap/2015-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2014-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd" namespace="http://xbrl.sec.gov/country/2013-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2014-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2015-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2011-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31"/>
<import schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2011-01-31"/>
<annotation>
<appinfo>
<link:roleType id="TemplateLink" roleURI="http://www.organovo.com/20150630/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
<link:definition> 00000 - Document - Template Link </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="onvo-20150630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="onvo-20150630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="onvo-20150630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="onvo-20150630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple"/>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
<link:definition> 100000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" id="Role_StatementCondensedConsolidatedBalanceSheets">
<link:definition> 100010 - Statement - Condensed Consolidated Balance Sheets </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="Role_StatementCondensedConsolidatedBalanceSheetsParenthetical">
<link:definition> 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations" id="Role_StatementUnauditedCondensedConsolidatedStatementsOfOperations">
<link:definition> 100030 - Statement - Unaudited Condensed Consolidated Statements of Operations </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" id="Role_StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
<link:definition> 100040 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlowsParenthetical" id="Role_StatementUnauditedCondensedConsolidatedStatementsOfCashFlowsParenthetical">
<link:definition> 100050 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows (Parenthetical) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies">
<link:definition> 100060 - Disclosure - Description of Business and Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDerivativeLiability" id="Role_DisclosureDerivativeLiability">
<link:definition> 100070 - Disclosure - Derivative Liability </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
<link:definition> 100080 - Disclosure - Stockholders' Equity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
<link:definition> 100090 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureConcentrations" id="Role_DisclosureConcentrations">
<link:definition> 100100 - Disclosure - Concentrations </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureRecentAccountingPronouncements" id="Role_DisclosureRecentAccountingPronouncements">
<link:definition> 100110 - Disclosure - Recent Accounting Pronouncements </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
<link:definition> 100120 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 100130 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables">
<link:definition> 100140 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDerivativeLiabilityTables" id="Role_DisclosureDerivativeLiabilityTables">
<link:definition> 100150 - Disclosure - Derivative Liability (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
<link:definition> 100160 - Disclosure - Stockholders' Equity (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
<link:definition> 100170 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<link:definition> 100180 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesEstimatedFairValuesOfLiabilitiesMeasuredOnRecurringBasisDetail" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesEstimatedFairValuesOfLiabilitiesMeasuredOnRecurringBasisDetail">
<link:definition> 100190 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Estimated Fair Values of Liabilities Measured on Recurring Basis (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesActivityForLiabilitiesMeasuredAtEstimatedFairValueUsingUnobservableInputsDetail" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesActivityForLiabilitiesMeasuredAtEstimatedFairValueUsingUnobservableInputsDetail">
<link:definition> 100200 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Activity for Liabilities Measured at Estimated Fair Value Using Unobservable Inputs (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail" id="Role_DisclosureDerivativeLiabilityAdditionalInformationDetail">
<link:definition> 100210 - Disclosure - Derivative Liability - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureDerivativeLiabilityAssumptionsUsedToValueDerivativeLiabilitiesAtClosingDatesOfPrivatePlacementsDetail" id="Role_DisclosureDerivativeLiabilityAssumptionsUsedToValueDerivativeLiabilitiesAtClosingDatesOfPrivatePlacementsDetail">
<link:definition> 100220 - Disclosure - Derivative Liability - Assumptions Used to Value Derivative Liabilities at Closing Dates of Private Placements (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityAdditionalInformationDetail">
<link:definition> 100230 - Disclosure - Stockholders' Equity - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRestrictedStockAwardActivityDetail" id="Role_DisclosureStockholdersEquitySummaryOfCompanySRestrictedStockAwardActivityDetail">
<link:definition> 100240 - Disclosure - Stockholders' Equity - Summary of Company's Restricted Stock Award Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation1Detail" id="Role_DisclosureStockholdersEquityAdditionalInformation1Detail">
<link:definition> 100250 - Disclosure - Stockholders' Equity - Additional Information 1 (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail" id="Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail">
<link:definition> 100260 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail" id="Role_DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail">
<link:definition> 100270 - Disclosure - Stockholders' Equity - Fair Value of Employee Stock Options (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation2Detail" id="Role_DisclosureStockholdersEquityAdditionalInformation2Detail">
<link:definition> 100280 - Disclosure - Stockholders' Equity - Additional Information 2 (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquitySummaryOfWarrantActivityDetail" id="Role_DisclosureStockholdersEquitySummaryOfWarrantActivityDetail">
<link:definition> 100290 - Disclosure - Stockholders' Equity - Summary of Warrant Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail" id="Role_DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail">
<link:definition> 100300 - Disclosure - Stockholders' Equity - Common Stock Reserved for Future Issuance (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
<link:definition> 100310 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.organovo.com/20150630/taxonomy/role/DisclosureCommitmentsAndContingenciesFutureMinimumRentalPaymentsRequiredUnderOperatingLeasesThatHaveInitialOrRemainingNonCancelableLeaseTermsInExcessOfOneYearDetail" id="Role_DisclosureCommitmentsAndContingenciesFutureMinimumRentalPaymentsRequiredUnderOperatingLeasesThatHaveInitialOrRemainingNonCancelableLeaseTermsInExcessOfOneYearDetail">
<link:definition> 100320 - Disclosure - Commitments and Contingencies - Future Minimum Rental Payments Required under Operating Leases that have Initial or Remaining Non-Cancelable Lease Terms in Excess of One Year (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</appinfo>
</annotation>
<element id="onvo_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_RevenueFromResearchCollaborations" name="RevenueFromResearchCollaborations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="onvo_IncreaseDecreaseInDeferredRent" name="IncreaseDecreaseInDeferredRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_ProceedsFromIssuanceOfCommonStockAndWarrants" name="ProceedsFromIssuanceOfCommonStockAndWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_LeaseholdImprovementsFundedByLeaseIncentive" name="LeaseholdImprovementsFundedByLeaseIncentive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_NatureOfOperationsAndBasisOfPresentationPolicyTextBlock" name="NatureOfOperationsAndBasisOfPresentationPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_RevenueRecognitionSingleElementArrangementsPolicyTextBlock" name="RevenueRecognitionSingleElementArrangementsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_RevenueRecognitionResearchAndDevelopmentRevenuePolicyTextBlock" name="RevenueRecognitionResearchAndDevelopmentRevenuePolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_RevenueRecognitionGrantPolicyTextBlock" name="RevenueRecognitionGrantPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_LiquidityPolicyTextBlock" name="LiquidityPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock" name="CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_PrivateMember" name="PrivateMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_NationalInstituteOfHealthResearchGrantMember" name="NationalInstituteOfHealthResearchGrantMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_CashAndCashEquivalentsMaturityPeriod" name="CashAndCashEquivalentsMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifiedToEquity" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifiedToEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_ResearchGrant" name="ResearchGrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="onvo_ClassOfWarrantOrRightLife" name="ClassOfWarrantOrRightLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability" name="NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_CombinationOfSecuritiesAuthorizedForOfferAndSale" name="CombinationOfSecuritiesAuthorizedForOfferAndSale" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_UnderwritingAgreementMember" name="UnderwritingAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_SecondaryOfferingMember" name="SecondaryOfferingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_EquityDistributionAgreementMember" name="EquityDistributionAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_EquityOfferingSalesAgreementMember" name="EquityOfferingSalesAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_EquityIncentivePlanTwoThousandEightMember" name="EquityIncentivePlanTwoThousandEightMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_EquityIncentivePlanTwoThousandTwelveMember" name="EquityIncentivePlanTwoThousandTwelveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_SaleOfStockPricePerShareNetOfFees" name="SaleOfStockPricePerShareNetOfFees" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="onvo_StockOptionExercisablePeriod" name="StockOptionExercisablePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_AdditionalCommonStockIssuedOnExerciseOfOptionByUnderwriters" name="AdditionalCommonStockIssuedOnExerciseOfOptionByUnderwriters" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="onvo_StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises" name="StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_TwoThousandTwelvePlanMember" name="TwoThousandTwelvePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_ShareBasedCompensationAwardYearlyVestingMember" name="ShareBasedCompensationAwardYearlyVestingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_WarrantsCashlessExerciseNumber" name="WarrantsCashlessExerciseNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_CashlessExerciseForIssuanceOfCommonStock" name="CashlessExerciseForIssuanceOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_NumberOfWarrantsExercised" name="NumberOfWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_AmountReversedAgainstOperatingExpense" name="AmountReversedAgainstOperatingExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<element id="onvo_ConsultationServiceAgreementSeptemberTwoThousandFourteenMember" name="ConsultationServiceAgreementSeptemberTwoThousandFourteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_ConsultationServiceAgreementNovemberTwoThousandFourteenMember" name="ConsultationServiceAgreementNovemberTwoThousandFourteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<element id="onvo_ClassOfWarrantsOrRightExercised" name="ClassOfWarrantsOrRightExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_WarrantOrRightExpenseOrRevenueRecognized" name="WarrantOrRightExpenseOrRevenueRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_WarrantEarningPeriodThroughIssuanceOfCommonStock" name="WarrantEarningPeriodThroughIssuanceOfCommonStock" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_CommonStockWarrantsIssued" name="CommonStockWarrantsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_OperatingLeasesMonthlyBaseRentExpense" name="OperatingLeasesMonthlyBaseRentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_LeaseTermWithOptionToExtend" name="LeaseTermWithOptionToExtend" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_IncreasedOfficeSpaceHeadquarters" name="IncreasedOfficeSpaceHeadquarters" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="onvo_AdditionalLeasedOfficeSpace" name="AdditionalLeasedOfficeSpace" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="onvo_OfficeSpaceAreaUnderLeaseAgreement" name="OfficeSpaceAreaUnderLeaseAgreement" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_OperatingLeasesMonthlyRentExpense" name="OperatingLeasesMonthlyRentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<element id="onvo_AdditionalOfficeSpace" name="AdditionalOfficeSpace" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_LeaseAmendmentEffectiveDate" name="LeaseAmendmentEffectiveDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_IncreaseOfNetAdjustmentLeasedSpace" name="IncreaseOfNetAdjustmentLeasedSpace" type="num:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<element id="onvo_LeaseRentalPeriodStartDate" name="LeaseRentalPeriodStartDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<element id="onvo_LeaseRentalPeriodEndDate" name="LeaseRentalPeriodEndDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</schema>

Top
Filing Submission 0001564590-15-006825   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 10:25:10.1pm ET